Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

OBJECTIVE: To explore the safety, efficacy, and biomarkers of bevacizumab with gemcitabine and oxaliplatin in women with recurrent platinum-sensitive ovarian carcinoma. METHODS: The patients received bevacizumab (10 mg/kg), gemcitabine (1000 mg/m(2)), and oxaliplatin (65 mg/m(2)) on days 1 and 15 in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Horowitz, Neil S., Penson, Richard T., Duda, Dan G., di Tomaso, Emmanuelle, Boucher, Yves, Ancukiewicz, Marek, Cohen, Kenneth S., Berlin, Suzanne, Krasner, Carolyn N., Moses, Marsha A., Jain, Rakesh K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3151740/
https://ncbi.nlm.nih.gov/pubmed/21833345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cloc.2011.04.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados